Logo image of CROS.PA

CROSSWOOD (CROS.PA) Stock Fundamental Analysis

Europe - EPA:CROS - FR0000050395 - Common Stock

10.7 EUR
+1.15 (+12.04%)
Last: 9/25/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CROS. CROS was compared to 75 industry peers in the Real Estate Management & Development industry. CROS has an excellent financial health rating, but there are some minor concerns on its profitability. CROS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CROS had positive earnings in the past year.
In the past year CROS had a positive cash flow from operations.
CROS had positive earnings in 4 of the past 5 years.
CROS had a positive operating cash flow in 4 of the past 5 years.
CROS.PA Yearly Net Income VS EBIT VS OCF VS FCFCROS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

The Return On Assets of CROS (5.39%) is better than 89.33% of its industry peers.
With a decent Return On Equity value of 6.53%, CROS is doing good in the industry, outperforming 74.67% of the companies in the same industry.
CROS has a Return On Invested Capital of 0.22%. This is in the lower half of the industry: CROS underperforms 61.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CROS is below the industry average of 4.00%.
Industry RankSector Rank
ROA 5.39%
ROE 6.53%
ROIC 0.22%
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)0.42%
ROIC(5y)0.55%
CROS.PA Yearly ROA, ROE, ROICCROS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8 10

1.3 Margins

CROS's Profit Margin of 615.20% is amongst the best of the industry. CROS outperforms 100.00% of its industry peers.
CROS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 29.62%, CROS is in the better half of the industry, outperforming 61.33% of the companies in the same industry.
CROS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 65.77%, CROS is in the better half of the industry, outperforming 62.67% of the companies in the same industry.
In the last couple of years the Gross Margin of CROS has declined.
Industry RankSector Rank
OM 29.62%
PM (TTM) 615.2%
GM 65.77%
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
CROS.PA Yearly Profit, Operating, Gross MarginsCROS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CROS is destroying value.
The number of shares outstanding for CROS remains at a similar level compared to 1 year ago.
The number of shares outstanding for CROS remains at a similar level compared to 5 years ago.
Compared to 1 year ago, CROS has an improved debt to assets ratio.
CROS.PA Yearly Shares OutstandingCROS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CROS.PA Yearly Total Debt VS Total AssetsCROS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.95 indicates that CROS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.95, CROS belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
CROS has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.07, CROS belongs to the best of the industry, outperforming 98.67% of the companies in the same industry.
CROS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, CROS belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 4.95
ROIC/WACC0.03
WACC7.97%
CROS.PA Yearly LT Debt VS Equity VS FCFCROS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 3.20 indicates that CROS has no problem at all paying its short term obligations.
CROS has a Current ratio of 3.20. This is in the better half of the industry: CROS outperforms 80.00% of its industry peers.
CROS has a Quick Ratio of 3.20. This indicates that CROS is financially healthy and has no problem in meeting its short term obligations.
CROS has a better Quick ratio (3.20) than 84.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.2
Quick Ratio 3.2
CROS.PA Yearly Current Assets VS Current LiabilitesCROS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 405.11% over the past year.
CROS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.78% yearly.
CROS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.55%.
Measured over the past years, CROS shows a very negative growth in Revenue. The Revenue has been decreasing by -10.37% on average per year.
EPS 1Y (TTM)405.11%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%607.53%
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-26.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CROS.PA Yearly Revenue VS EstimatesCROS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.98, the valuation of CROS can be described as rather expensive.
CROS's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.06, CROS is valued a bit cheaper.
Industry RankSector Rank
PE 20.98
Fwd PE N/A
CROS.PA Price Earnings VS Forward Price EarningsCROS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CROS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 73.52
EV/EBITDA N/A
CROS.PA Per share dataCROS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

CROS has a Yearly Dividend Yield of 2.14%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 7.76, CROS has a dividend in line with its industry peers.
CROS's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.14%

5.2 History

On average, the dividend of CROS grows each year by 156.54%, which is quite nice.
Dividend Growth(5Y)156.54%
Div Incr Years0
Div Non Decr Years0
CROS.PA Yearly Dividends per shareCROS.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.1 0.2 0.3

5.3 Sustainability

19.46% of the earnings are spent on dividend by CROS. This is a low number and sustainable payout ratio.
DP19.46%
EPS Next 2YN/A
EPS Next 3YN/A
CROS.PA Yearly Income VS Free CF VS DividendCROS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M
CROS.PA Dividend Payout.CROS.PA Dividend Payout, showing the Payout Ratio.CROS.PA Dividend Payout.PayoutRetained Earnings

CROSSWOOD

EPA:CROS (9/25/2025, 7:00:00 PM)

10.7

+1.15 (+12.04%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners63.64%
Inst Owner ChangeN/A
Ins Owners95.04%
Ins Owner ChangeN/A
Market Cap113.74M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.14%
Yearly Dividend0.1
Dividend Growth(5Y)156.54%
DP19.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.98
Fwd PE N/A
P/S 128.09
P/FCF 73.52
P/OCF 55.87
P/B 1.36
P/tB 1.36
EV/EBITDA N/A
EPS(TTM)0.51
EY4.77%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY1.36%
OCF(TTM)0.19
OCFY1.79%
SpS0.08
BVpS7.87
TBVpS7.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.39%
ROE 6.53%
ROCE 0.26%
ROIC 0.22%
ROICexc 0.23%
ROICexgc 0.23%
OM 29.62%
PM (TTM) 615.2%
GM 65.77%
FCFM 174.21%
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)0.42%
ROIC(5y)0.55%
ROICexc(3y)0.43%
ROICexc(5y)0.56%
ROICexgc(3y)0.43%
ROICexgc(5y)0.56%
ROCE(3y)0.52%
ROCE(5y)0.67%
ROICexcg growth 3Y-25.56%
ROICexcg growth 5Y-29.72%
ROICexc growth 3Y-25.56%
ROICexc growth 5Y-29.71%
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 55.07%
Interest Coverage 3.06
Cash Conversion N/A
Profit Quality 28.32%
Current Ratio 3.2
Quick Ratio 3.2
Altman-Z 4.95
F-Score5
WACC7.97%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)39.93%
Cap/Sales(5y)36.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)405.11%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%607.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-26.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.21%
EBIT growth 3Y-25.77%
EBIT growth 5Y-27.97%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y723.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y475.14%
OCF growth 3Y52.86%
OCF growth 5YN/A